Hikma Pharmaceuticals Plc Block listing Interim Review (3526O)
October 02 2023 - 5:13AM
UK Regulatory
TIDMHIK
RNS Number : 3526O
Hikma Pharmaceuticals Plc
02 October 2023
Hikma Pharmaceuticals PLC
Block Listing Six Monthly Return
Date: 2 October 2023
Name of applicant: Hikma Pharmaceuticals PLC
Name of scheme: Hikma Pharmaceuticals PLC 2018 Management Incentive Plan ("2018 MIP") and Hikma
Pharmaceuticals
PLC 2014 Executive Incentive Plan ("EIP") (together "the Plans")
----------------------------------------------------------------------------------
Period of return From: 1 April 2023 To: 30 September 2023
---------------------------------- --------- -----------------------------------
Balance of unallotted securities The Plans: 1,497,913 Ordinary Shares of 10 pence
under scheme(s) from previous
return:
----------------------------------------------------------------------------------
Plus: The amount by which the The Plans: 0 Ordinary Shares of 10 pence
block scheme(s) has been
increased since the date of the
last
return (if any increase has been
applied for):
----------------------------------------------------------------------------------
Less: Number of securities 2018 MIP: 438 Ordinary Shares of 10 pence
issued/allotted under scheme(s) EIP: 378,765 Ordinary Shares of 10 pence
during period (see LR3.5.7G):
----------------------------------------------------------------------------------
Equals: Balance under scheme(s) The Plans: 1,118,710 Ordinary Shares of 10 pence
not yet issued/allotted at end of
period:
----------------------------------------------------------------------------------
Name of contact: Hussein Arkhagha
Telephone number of contact: +44(0)20 7399 2760
-------------------
LEI: 549300BNS685UXH4JI75
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BLRUPGPGUUPWUBP
(END) Dow Jones Newswires
October 02, 2023 05:13 ET (09:13 GMT)
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Sep 2024 to Oct 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Oct 2023 to Oct 2024